DESALLES BARTOLOMEO EDUARDO reported acquisition or exercise transactions in this Form 4 filing.
Albemarle Corporation director Desalles Bartolomeo Eduardo received a grant of 1,375 shares of common stock as non-employee director compensation. The pro rata award, made under the Albemarle Corporation 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors, was granted on July 21, 2026 and is scheduled to vest on July 1, 2027. Following this award, he directly holds 1,375 common shares.
Albemarle Corp director DeSalles Bartolomeo Eduardo has filed an initial Form 3 as a reporting person in the capacity of director only, not as an officer or 10% owner. The report shows no equity transactions or derivative positions and references an Exhibit 24 power of attorney authorization.
Albemarle Corporation appointed Eduardo De Salles Bartolomeo as an independent member of its Board of Directors, effective July 21, 2026. He joins the Board’s Audit and Finance Committee and Safety, Sustainability, Operations & Capital Committee.
Under the non-employee director compensation program, Bartolomeo will receive a $120,000 annual cash retainer and an annual restricted stock grant valued at $170,000, both pro-rated for his partial year of service in 2026, with the stock amount rounded up to the nearest 25 shares. Albemarle highlights his more than 30 years of leadership in global mining and logistics, including service as Chief Executive Officer of Vale S.A. from 2019 to 2024 and other senior roles in metals and logistics businesses, as well as his current board role at Boston Metal, Inc.
ALBEMARLE CORP director Glenda J. Minor received a grant of 1,250 Phantom Stock units tied to common shares. The award represents non-employee director stock compensation under the 2023 Directors Plan and converts into common stock on a 1-for-1 basis.
The units are scheduled to vest on July 1, 2027 and are payable as shares of common stock upon events she establishes under the plan’s terms. Following this grant, Minor holds a total of 5,606 Phantom Stock units, which also accrue dividend equivalent rights and have no expiration date.
Collins Michelle T reported acquisition or exercise transactions in this Form 4 filing.
ALBEMARLE CORP director Michelle T. Collins reported stock-based compensation grants, not open-market trades. On July 1, 2026 she received 1,250 shares of common stock as an annual non-employee director award under the 2023 Directors Plan, scheduled to vest on July 1, 2027. She also received 2 additional shares representing dividends accrued on a prior award granted on February 26, 2026 that fully vested on July 1, 2026.
Albemarle Corporation director Ralf Hans Cramer reported routine equity compensation and related tax withholding in company stock. On July 1, 2026, he received an annual non-employee director stock award and additional shares from dividends settled in stock under the 2023 Directors Plan. On the same date, a portion of shares from these vesting awards and dividend equivalents was withheld at $136.08 per share to cover associated tax liabilities, rather than sold in the open market. The transactions reflect compensation and tax mechanics, not discretionary buying or selling of Albemarle shares.
ALBEMARLE CORP director Laurie Brlas reported equity awards of common stock as part of non-employee director compensation. On July 1, 2026, Brlas received two acquisitions of common stock valued at $0.00 per share, reflecting stock-based compensation rather than open-market purchases.
The filing shows an award of 1,250 shares of common stock as an annual installment of non-employee director stock compensation under the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation, scheduled to vest on July 1, 2027. It also shows 36 shares issued for dividends accrued on a prior award granted on July 1, 2025 that vested in full on July 1, 2026, which the company elected to settle in stock under the same plan.
After these awards, Brlas holds 7,289 shares of Albemarle common stock directly and 6,900 shares indirectly through a spouse, according to the filing.
ALBEMARLE CORP director Alejandro Daniel Wolff acquired additional equity-based compensation and dividend-related holdings in the company. He received 33 shares of common stock at no cost through an automatic dividend reinvestment program and now directly holds 13,044 common shares.
He also was granted 1,250 Phantom Stock units, which convert 1-for-1 into common stock and are payable as shares under the 2023 Directors Plan, bringing his Phantom Stock balance to 7,590 units. These Phantom Stock amounts include dividend equivalent rights and represent an annual non-employee director stock installment scheduled to vest on July 1, 2027.
Albemarle Corporation director Mark R. Widmar received an equity-based compensation award. He was granted 1,250 Phantom Stock units that convert one-for-one into Albemarle common stock. Following this grant, he holds 1,576 Phantom Stock units in his deferred stock account.
The units are an annual non-employee director stock compensation award under Albemarle’s 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors and are payable in shares of common stock upon distribution events selected under the plan. The award is scheduled to vest on July 1, 2027 and has no expiration date.
Albemarle Corporation director Gerald A. Steiner reported stock-based compensation awards rather than open-market trades. He acquired 36 shares of common stock as an annual non-employee director stock compensation installment under the 2023 Directors Plan, scheduled to vest on July 1, 2027. He also received 1,250 additional shares that represent dividends accrued on a prior stock award granted on July 1, 2025 and vested on July 1, 2026, which the company elected to settle in shares. These transactions reflect equity compensation grants and dividend equivalents, not cash purchases or sales.